子宫内膜异位症腹腔镜子宫切除术的手术结局与并发症:一项多中心队列研究
该回顾性多中心队列研究纳入2010年1月至2020年12月8个欧洲微创转诊中心995例病理确诊子宫内膜异位症和/或子宫腺肌症、行全腹腔镜子宫切除术且未合并泌尿或胃肠手术的患者,评估术后30天内Clavien-Dindo≥2级主要并发症。术中并发症发生率3%,主要术后并发症93例(9.3%)。多因素分析显示既往子宫内膜异位症手术(OR 1.62,95%CI 1.01-2.60)和术中并发症(OR 6.49,95%CI 2.65-16.87)为主要事件预测因素,年龄(OR 0.94,95%CI 0.90-0.99)和术前药物治疗(OR 0.50,95%CI 0.31-0.81)与主要并发症呈负相关。
要点
- 995例子宫内膜异位症/子宫腺肌症患者行腹腔镜子宫切除术,术中并发症3%,主要术后并发症9.3%。
- 既往子宫内膜异位症手术(OR 1.62)和术中并发症(OR 6.49)与主要并发症风险升高相关。
- 年龄(OR 0.94)和术前药物治疗(OR 0.50)与主要并发症风险降低相关。
核心结论
- 子宫内膜异位症/子宫腺肌症行腹腔镜子宫切除术伴随不可忽视的并发症发生率。
- 了解与并发症高风险相关的因素可用于风险分层,并可能有助于临床医生进行术前咨询。
- 术前使用雌激素-孕激素或孕激素可能降低术后并发症风险。
研究设计与样本
- 回顾性多中心队列研究,纳入8个欧洲微创转诊中心。
- 共995例病理确诊子宫内膜异位症和/或子宫腺肌症、行全腹腔镜子宫切除术且未合并泌尿和/或胃肠手术的患者,手术时间为2010年1月至2020年12月。
- 评估人口学特征、手术结局及术中术后并发症,主要术后并发症定义为术后30天内发生的Clavien-Dindo评分≥2级的任何事件。
- 采用单因素分析和逻辑回归多因素模型估计主要并发症的校正比值比(OR)及95%置信区间(CI)。
主要发现
- 手术时中位年龄44岁(28-54),505例(50.7%)在手术时正在接受药物治疗(雌激素-孕激素、孕激素或促性腺激素释放激素类似物)。
- 与腹腔镜子宫切除术同时行后壁粘连松解387例(38.9%),深部结节切除302例(30.0%)。
- 术中并发症发生率为3%,主要术后并发症登记93例(9.3%)。
- 多因素分析显示,Clavien-Dindo>2级并发症的发生与年龄呈负相关(OR 0.94,95%CI 0.90-0.99)。
- 既往子宫内膜异位症手术(OR 1.62,95%CI 1.01-2.60)和术中并发症(OR 6.49,95%CI 2.65-16.87)为主要事件的预测因素;手术时药物治疗为保护因素(OR 0.50,95%CI 0.31-0.81)。
临床怎么用
- 了解与并发症高风险相关的因素可用于风险分层,并可能有助于临床医生进行术前咨询。
- 术前使用雌激素-孕激素或孕激素可能降低术后并发症风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To investigate the postoperative morbidity of laparoscopic hysterectomy (LH) for endometriosis/adenomyosis in terms of operative outcomes and complications. DESIGN: Retrospective multicentric cohort study. SETTING: Eight European minimally invasive referral centers. PATIENTS: Data from 995 patients with pathologically confirmed endometriosis and/or adenomyosis who underwent LH without concomitant urological and/or gastroenterological procedures from January 2010 to December 2020. INTERVENTIONS: Total LH. MEASUREMENTS AND MAIN RESULTS: Demographic patients' characteristics, surgical outcomes, and intraoperative and postoperative complications were evaluated. We considered major postoperative surgical-related complications, any grade 2 or more events (Clavien-Dindo score) that occurred within 30 days from surgery. Univariate analysis and multivariable models fit with logistic regression were used to estimate the adjusted odds ratio (OR) and corresponding 95% confidence interval (CI) for major complications. Median age at surgery was 44 years (28-54), and about half of them (505, 50.7%) were on medical treatment (estro-progestins, progestin, or Gonadotropin hormone-releasing hormone-analogues) at the time of surgery. In association with LH, posterior adhesiolysis was performed in 387 (38.9%) cases and deep nodule resection in 302 (30.0%). Intraoperative complications occurred in 3% of the patients, and major postoperative complications were registered in 93 (9.3%). The multivariable analysis showed an inverse correlation between the occurrence of Clavien-Dindo >2 complications and age (OR 0.94, 95% CI 0.90-0.99), while previous surgery for endometriosis (OR 1.62, 95% CI 1.01-2.60) and intraoperative complications (OR 6.49, 95% CI 2.65-16.87) were found as predictors of major events. Medical treatment at the time of surgery has emerged as a protective factor (OR 0.50, 95% CI 0.31-0.81). CONCLUSION: LH for endometriosis/adenomyosis is associated with non-negligible morbidity. Knowing the factors associated with higher risks of complications might be used for risk stratification and could help clinicians during preoperative counseling. The administration of estro-progestin or progesterone preoperatively might reduce the risks of postoperative complications following surgery.
引用
- Casarin J, Ghezzi F, Mueller M, et al. Surgical Outcomes and Complications of Laparoscopic Hysterectomy for Endometriosis: A Multicentric Cohort Study. J Minim Invasive Gynecol. 2023. PMID: 37004810. doi:10.1016/j.jmig.2023.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。